Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer-Reference-Cited by-同舟云学术

Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer

Published:2009-03 Issue:2 Volume:27 Page:155-159
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Lerner Seth P.,Tangen Catherine M.,Sucharew Heidi,Wood David,Crawford E. David

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference20 articles.

1. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: Effect of bacillus Calmette-Guerin viability on treatment results;Kelley;J Urol,1985

2. Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: 10-year follow-up of a prospective randomized trial;Herr;J Clin Oncol,1995

3. Management of Stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy;Cookson;J Urol,1992

4. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1A, and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study;Lamm;J Urol,2000

5. A Phase IIB trial of BCG combined with interferon alpha for bladder cancer;Esuvaranathan;J Urol,2000

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to 2 Induction Courses of Bacillus Calmette-Guèrin Therapy Among Patients With High-Risk Non–Muscle-Invasive Bladder Cancer;JAMA Oncology;2024-04-01

2. Strategies for Overcoming Immune Evasion in Bladder Cancer;International Journal of Molecular Sciences;2024-03-07

3. BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies;Frontiers in Neuroscience;2024-01-08

4. Novel immunotherapeutic options for BCG‐unresponsive high‐risk non‐muscle‐invasive bladder cancer;Cancer Medicine;2023-12

5. Prognostic Role of Preoperative Neutrophil-To-Lymphocyte Ratio (NLR) and Recurrence at First Evaluation after Bacillus Calmette–Guérin (BCG) Induction in Non-Muscle-Invasive Bladder Cancer;Diagnostics;2023-10-02